These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2035 related articles for article (PubMed ID: 25613154)

  • 1. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.
    Gravas S; Gacci M; Gratzke C; Herrmann TRW; Karavitakis M; Kyriazis I; Malde S; Mamoulakis C; Rieken M; Sakalis VI; Schouten N; Speakman MJ; Tikkinen KAO; Cornu JN
    Eur Urol; 2023 Aug; 84(2):207-222. PubMed ID: 37202311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].
    Oelke M; Abt SD; Becher KF; Dreikorn K; Madersbacher S; Magistro G; Michel MC; Muschter R; Reich O; Rieken M; Salem J; Schönburg S; Höfner K; Bschleipfer T
    Urologie; 2023 Aug; 62(8):805-817. PubMed ID: 37401972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial assessment and follow-up of benign prostatic hyperplasia: systematic review of the literature by the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; de la Taille A;
    Prog Urol; 2012 Jan; 22(1):1-6. PubMed ID: 22195998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to evaluate BPH-related SBAUs in clinical practice and research?].
    Descazeaud A; Robert G; de La Taille A
    Prog Urol; 2018 Nov; 28(15):830-838. PubMed ID: 30220536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics of benign prostate syndrome].
    Seitz M; Herlemann A; Magistro G; Stief CG
    Urologe A; 2013 Feb; 52(2):193-6. PubMed ID: 23417045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].
    Bschleipfer T; Oelke M; Rieken M
    Urologe A; 2019 Mar; 58(3):238-247. PubMed ID: 30796463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CROATIAN UROLOGISTS' CLINICAL PRACTICE AND COMPLIANCE WITH GUIDELINES IN THE MANAGEMENT OF NON-NEUROGENIC MALE LOWER URINARY TRACT SYMPTOMS.
    Tomasković I; Tomić M; Nikles S; Neretljak I; Milicić V
    Acta Clin Croat; 2015 Dec; 54(4):453-7. PubMed ID: 27017719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.
    Homma Y; Gotoh M; Kawauchi A; Kojima Y; Masumori N; Nagai A; Saitoh T; Sakai H; Takahashi S; Ukimura O; Yamanishi T; Yokoyama O; Yoshida M; Maeda K
    Int J Urol; 2017 Oct; 24(10):716-729. PubMed ID: 28748576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
    Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
    Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Christian Gratzke, Alexander Bachmann, Aurelien Descazeaud, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol 2015;67:1099-109.
    Tubaro A; De Nunzio C
    Eur Urol; 2015 Jul; 68(1):e15. PubMed ID: 25770488
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
    Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
    BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Distribution of Postvoid Residual Urine Volume in a Hospital-Based Sample of Men with Symptomatic Benign Prostatic Hyperplasia.
    Anyimba SK; Amu OC; Nnabugwu II; Okoh AD; Nwachukwu CD; Iwenofu CA
    Niger J Clin Pract; 2023 Dec; 26(12):1839-1843. PubMed ID: 38158350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.